In 1984 The Medical Alley Association was started by Lee Berlin and Earl Bakken (with the help of many others). Lee was the CEO of a company called LecTec, which made transdermal drug delivery patches. From day one Medical Alley meant biotech and pharmaceutical.
When MNBIO and Medical Alley merged in 2006, there were 15 human health bio/pharma members. Today, there are 125; second only to Medical Device. The bio/pharma community is critical to the success of Medical Alley - the region and the association.
The biotech and pharmaceutical sectors provide ways of diagnosing and treating disease that devices can't (and devices provide ways that dugs can't). The companies bring a diversity of technology and unique approaches to problem solving. Bio/pharma employs many graduates coming out of the University of Minnesota. For so many reasons, this sector is critical.
Delivering value to bio/pharma members:
1. The Great State of Pharmaceuticals and Biotechnology 2016 – powered by PhRMA: For the first time, the Medical Alley Association is hosting a one-day conference filled with exceptional industry content and the opportunity to connect with suppliers, consultants and peers to fuel the connectivity of our Medical Alley community. It’s a trade fair, a conference, an exhibition and a networking event – all focused on this growing pharmaceuticals and biotechnology hub! Keynote Steve Ubl, CEO and President of PhRMA will kick off the conference.
2. Connections: Through introductions and our popular BioPharma Alley Chats, members meet their peers, find suppliers, find investors and most importantly - find community in a place known for Medical Device.
3. Information: Through our research and seminars, they gain knowledge and information that helps them make better decisions. This includes sector research like our Tissue Biologics report and data from our investment study.
4. Policy work: Through our active state and federal policy practice, we work to advance policy beneficial to biotech and pharmaceutical companies. This has included investment incentives, stopping harmful regulations of clinical trials at the state level and supporting internship money to prepare new workforce for the growing community.
5. Operational Savings: Through our affiliation with the $500 million/year purchasing group, biotech and pharmaceutical members save on lab supplies and instruments, lab coats and clean room gear, office supplies, insurance and much more.
For these reasons and many more, biotech and pharmaceutical organizations support a nearly 100% renewal rate each year - our highest of any group. Thank you for your membership and engagement as we enjoy great growth in this sector.